Quantcast

Latest Aminoacyl tRNA synthetase Stories

2010-05-25 05:00:00

SAN DIEGO, May 25 /PRNewswire/ -- aTyr announced today that John Mendlein, Ph. D., has joined their Board of Directors as Executive Chairman. The translation of aTyr's newly found class of proteins, resectins, into medicines of the future will benefit from Dr. Mendlein's experience in biologics, partnerships, and product strategy. Resectins may serve as potential replacement protein therapeutics or as targets for antagonists relevant to inflammation, blood disorders, and metabolic...

2009-12-14 12:45:46

The work provides insight into potential therapeutic for cancer and eye diseases Researchers at The Scripps Research Institute have solved a 10-year-old mystery of how a single protein from an ancient family of enzymes can have two completely distinct roles in the body. In addition to providing guidance for understanding other molecules in the family, the research supplies a theoretical underpinning for the protein's possible use for combating diseases including cancer and macular...

2009-12-14 05:00:00

SAN DIEGO, Dec. 14 /PRNewswire/ -- Research published in the December 13, 2009 edition of Nature Structural Biology uncovers the structural basis for the multifunctionality of aminoacyl tRNA synthetases. Aminoacyl tRNA synthetases are universal and essential enzymes of protein synthesis machinery found in all organisms. However, human synthetases and naturally occurring variants of these enzymes have additional activities that are vital to normal functioning of the complex human system...

2009-10-14 05:00:00

SAN DIEGO, Oct. 14 /PRNewswire/ -- aTyr Pharma announced today that Dr. Floyd Bloom Professor Emeritus, Molecular and Integrative Neuroscience Department at The Scripps Research Institute, has joined their scientific advisory board. A widely acknowledged leader in the field of neurosciences, Dr. Bloom has been recognized with many honors, including elected membership to the National Academy of Sciences, the Institute of Medicine, the American Philosophical Society and the Royal Swedish...

2009-10-07 05:00:00

SAN DIEGO, Oct. 7 /PRNewswire/ -- aTyr Pharma, Inc., a biopharmaceutical company discovering and developing a new class of naturally occurring proteins as biotherapeutics, will present at the BioPartnering Europe Conference in London on Monday October 12. Jeff Watkins, CEO of aTyr Pharma, will provide an overview of aTyr Pharma's technology, product engine, and lead program based on naturally occurring resected proteins of the tRNA synthetases. The aminoacyl tRNA synthetases are...

2009-09-29 05:00:00

SAN DIEGO, Sept. 29 /PRNewswire/ -- aTyr Pharma announced today that Professor Osamu Nureki, Department of Basic Medical Sciences of the Institute of Medical Science at the University of Tokyo, has joined their scientific advisory board. A globally-recognized expert in protein crystallography, Professor Nureki is well known for his contributions in elucidating the structures of aminoacyl tRNA synthetases. The tRNA synthetases are key enzymes in protein synthesis, but have recently...

2009-09-24 13:23:00

SAN DIEGO, Calif., Sept. 24 /PRNewswire/ -- aTyr Pharma, Inc., a biopharmaceutical company discovering and developing a new class of naturally occurring proteins as biotherapeutics, will present at the Japan Biopharma Conference in Tokyo on Tuesday October 6. Jeff Watkins, CEO of aTyr Pharma, will provide an overview of aTyr Pharma's technology, product engine, and lead program based on naturally occurring resected proteins of the tRNA synthetases. The aminoacyl tRNA synthetases are...

2009-09-14 12:28:00

SAN DIEGO, Sept. 14 /PRNewswire/ -- aTyr Pharma, Inc., a biopharmaceutical company discovering and developing a new class of naturally occurring proteins as biotherapeutics, will present at the BioPharm America 2009 conference in San Francisco, CA on Friday, September 18th. Jeff Watkins, CEO of aTyr Pharma, will present an overview of aTyr Pharma's technology, product engine, and lead program based on naturally occurring resected proteins of the tRNA synthetases. The aminoacyl tRNA...

2009-09-09 05:00:00

SAN DIEGO, Sept. 9 /PRNewswire/ -- aTyr Pharma announced today that the US Patent office has issued patent US 7,572,452 B2, titled "Method for Stimulating Wound Healing." aTyr Pharma is the sole assignee of this patent, and Professor Sunghoon Kim, a scientific co-founder of aTyr Pharma, is the inventor. An example of aTyr Pharma's broad intellectual property portfolio and the fifteenth filed patent related to aTyr Pharma's work in tRNA synthetases, this patent covers new extracellular...

2009-08-06 14:27:00

As letters of the alphabet spell out words, when amino acids are linked to one another in a particular order they "spell out" proteins. But sometimes the cell machinery for building proteins in our bodies makes a mistake and the wrong amino acid is inserted. The consequences can be devastating, resulting in a garbled protein that no longer has the correct function, possibly leading to cancers and other diseases.Now scientists at The Scripps Research Institute have examined how an enzyme...


Word of the Day
attercop
  • A spider.
  • Figuratively, a peevish, testy, ill-natured person.
'Attercop' comes from the Old English 'atorcoppe,' where 'atter' means 'poison, venom' and‎ 'cop' means 'spider.' 'Coppa' is a derivative of 'cop,' top, summit, round head, or 'copp,' cup, vessel, which refers to 'the supposed venomous properties of spiders,' says the OED. 'Copp' is still found in the word 'cobweb.'
Related